BIOQUAL, INC.
BIOQ
60.0
| Payment Date | Dividend | Yield |
|---|---|---|
|
Oct 27, 2022
|
1
|
1.282%
|
|
Oct 20, 2021
|
1.25
|
1.603%
|
|
Oct 21, 2020
|
1.1
|
1.41%
|
|
Oct 16, 2019
|
0.7
|
0.897%
|
|
Oct 10, 2018
|
0.6
|
0.769%
|
|
Oct 11, 2017
|
0.6
|
0.769%
|
|
Sep 05, 2001
|
0.04
|
1.584%
|
|
Sep 07, 2000
|
0.03
|
1.345%
|
|
Date
|
Consensus EPS
|
Eps
|
Consensus Revenue
|
Revenue
|
|---|---|---|---|---|
|
Oct 19
|
N/A | N/A | N/A | N/A |
|
Sep 21
|
N/A | N/A | N/A | N/A |
|
Sep 20
|
N/A | 0.79 | N/A | N/A |
|
Sep 19
|
N/A | N/A | N/A | N/A |
|
Sep 18
|
N/A | N/A | N/A | N/A |
|
Sep 17
|
N/A | N/A | N/A | N/A |
|
Apr 21
|
-1.27 | -1.27 | N/A | N/A |
|
Apr 19
|
N/A | N/A | N/A | N/A |
BIOQ Profile
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.